Klingman & Associates’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,517	Closed	-$85.4K	–	268
2024 Q4	$85.4K	Buy	10,517 +141	+1%	+$1.15K	0.01%	255
2024 Q3	$188K	Hold	10,376	–	–	0.01%	261
2024 Q2	$107K	Hold	10,376	–	–	0.01%	246
2024 Q1	$110K	Buy	+10,376	New	+$110K	0.01%	235